跳至主要内容
临床试验/NCT04072406
NCT04072406终止不适用

A Self-Directed Mindfulness Meditation Intervention in Gynecologic Cancer Patients

Washington University School of Medicine2 个研究点 分布在 1 个国家目标入组 21 人开始时间: 2019年7月23日最近更新:
适应症

试验速览

阶段
不适用
状态
终止
入组人数
21
试验地点
2
主要终点
Change in symptoms of anxiety as measured by the Hospital Anxiety and Depression Scale (HADS)

研究概览

简要总结

The current study examines the effects of a 3-week, at-home mindfulness mediation intervention (MMI) to address psychological and physical distress in patients with gynecologic cancer.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Must be ≥ 18 years old
  • Have a diagnosis of Stage III or IV, progressive or recurrent GC (endometrial, ovarian, fallopian tube, primary peritoneal, cervical, vulvar, vaginal, or other)
  • Be native English speakers
  • Report ≥ 4 on the National Cancer Care Network (NCCN) Distress Thermometer at the time of recruitment;
  • Not currently be practicing weekly meditation
  • Be willing to create (or already have) an email address
  • Have access to internet via a personal electronic device (or be willing to borrow an internet-enabled tablet from the study team).

排除标准

  • <18 years old
  • Distress Thermometer ratings ≤ 3
  • Non-native English speakers
  • Individuals with severe depression, and individuals who are having suicidal thoughts.
  • Individuals who are also not willing to create an email address for the purpose of the study (or individuals who do not have an email address already)
  • Individuals who are currently practicing weekly meditation
  • Due to overlap in surveys for other ongoing trials in the Division of Gynecologic Oncology, patients may not be currently enrolled on protocol IRB#: 201511102 (chemoresistance) or IRB# 201804169 (Cytokine-induced depression).

结局指标

主要结局

Change in symptoms of anxiety as measured by the Hospital Anxiety and Depression Scale (HADS)

时间窗: From Baseline to week 3

-On the 14-item Hospital Anxiety and Depression Scale (HADS) symptoms of anxiety (7) and depression (7) are rated on a scale from 0 (less severe) to 3 (more severe).

次要结局

  • Change in symptoms of fatigue as measured by the Brief Fatigue Inventory (BFI)(From Baseline to week 3)
  • Change in symptoms of distress as measured by the National Comprehensive Cancer Network Distress Thermometer(From Baseline to week 3)
  • Change in symptoms of depression as measured by the Hospital Anxiety and Depression Scale (HADS)(From Baseline to week 3)
  • Change in overall physical symptoms as measured by the Edmonton Symptoms Associated Scale Revised(From Baseline to week 3)
  • Change in emotion regulation as measured by the Emotion Regulation Questionnaire(From Baseline to week 3)
  • Change in perceived stress as measured by the Perceived Stress Scale(From Baseline to week 3)
  • Change in coping as measured by the Cognitive Emotion Regulation Questionnaire(From Baseline to week 3)
  • Change in mindfulness as measured by the Five-Facet Mindfulness Questionnaire(From Baseline to week 3)
  • Change in self-compassion as measured by the Sussex-Oxford Compassion for Self Scale(From Baseline to week 3)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

A Self-Directed Mindfulness Meditation Intervention... | 临床试验